Trial intelligence / Profile preview

Biomarkers for response to anti-VEGF therapy in diabetic macular edema

jRCT1080223989Recruiting

Sponsor
Santen Pharmaceutical
Start
Jul 2018
Countries
1
01

Overview

Open-label, single-arm trial in diabetic macular edema (DME), sponsored by Santen Pharmaceutical. Started Jul 2018; status: recruiting.

02

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on jRCT1080223989.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223989.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call